Bernstein SocGen Group analyst Lance Wilkes reiterated an Outperform rating and $411.00 price target on UnitedHealth Group (NYSE: UNH).

The analyst commented: "We see 1) a sector turnaround as MA recovers from trough margins following the MA rate shock and withdrawal of competition; 2) company-specific margin turnaround as UNH exits unprofitable MA and Optum Health products; 3) UNH valuation is attractive given our expectation for strong EPS growth recovery over the next 4 years. "

For an analyst ratings summary and ratings history on UnitedHealth Group click here. For more ratings news on UnitedHealth Group click here.

Shares of UnitedHealth Group closed at $316.40 yesterday.